U.S. Anticoagulant And Antiplatelet Therapies Markets

U.S. Anticoagulant And Antiplatelet Therapies Markets

 

RELEASE DATE
16-Sep-2002
REGION
North America
Research Code: A281-01-00-00-00
SKU: HC00844-NA-MR_04554
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC00844-NA-MR_04554

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This report provides revenue forecasts, market shares, projected incidence and prevalence numbers, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely anticoalugants and antiplatelets, each sub-segmented into oral and injection markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Table of Contents

Overview

  • Scope and Segmentation
  • Therapeutic Overview
  • Disease Overview
  • Economic Impact of Cardiovascular Diseases
  • Challenges and Strategies

Market Dynamics

  • Demand Analysis - I
  • Demand Analysis - II
  • Market and Technology Trends
  • Revenue Forecast

Frost & Sullivan Market Engineering Awards

  • Market Engineering Leadership: Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership
  • Technology Leadership: Sanofi-Synthelabo
  • Business Development Strategy : Aventis Pharmaceuticals
  • Technology Innovation: AstraZeneca
  • Merger & Acquisition Strategy: Bristol-Myers Squibb

Overview

Competitive Analysis

Oral Anticoagulant Therapies Market

  • Introduction
  • Market Engineering Analysis
  • Revenue Forecast

Injection Anticoagulant Therapies Market

  • Competitive Structure
  • Market Share Analysis

Overview

Competitive Analysis

Oral Antiplatelet Therapies Market

Injection Antiplatelet Therapies Market

Related Research
This report provides revenue forecasts, market shares, projected incidence and prevalence numbers, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely anticoalugants and antiplatelets, each sub-segmented into oral and injection markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A281-01-00-00-00
Is Prebook No